The National Institutes of Health U.S. FDA (NIH) has collaborated to launch a study to assess the impact of tobacco product risk persistence information on different populations and to provide data to support public education strategies.
According to the U.S. Food and Drug Administration’s data (FDA) website on August 21, the FDA Center for Tobacco Products (CTP) and the National Institutes of Health (NIH) today.
The Cooperative Agreement Grant (U01) was awarded to the grant project titled, “From Cognitive to Behavioral: Comprehensive Approach to Examining the Persistent Impacts of Public Health Communication Messages on the Risks of Tobacco Products .”
The project’s Principal Investigators are Meghan Moran, Ph.D., of Johns Hopkins University, and Andy Tan, Ph.D., of the University of Pennsylvania. who will conduct health communication research to better understand how messages about the risk continuum of tobacco products may affect different populations.
Optimize the dissemination of public health information
The study, first announced through a Notice of Funding Opportunity released in August 2023, is designed to provide CTP with data to help it develop implicit public education that communicates the concept of risk sustainability of tobacco products, i.e., that there is a spectrum of health risks associated with different tobacco products.
Specifically. This study will examine how to accurately communicate relative risks to adults who use combustible cigarettes and ensure that these messages do not appeal to other audiences, especially youth.
According to the FDA, current research in this area is limited, and this project hopes to fill this gap by collecting data that will optimize public health communication on this topic. To educate smokers about current research. The agency released a new website in April 2024 on the relative risks of tobacco products, including vapes.
This cooperative agreement results from a recent subsidy from the Cigarette Regulation Science Program (TRSP), a long-standing interagency partnership between the FDA and NIH to promote research on cigarette control.
